title: The effect of tocilizumab on the uptake of 18FDG-PET imaging in patients with adult-onset Still's disease.
authors.forename: Marcelo L
authors.initials: ML
authors.lastname: Cunha
authors.forename: Jairo
authors.initials: J
authors.lastname: Wagner
authors.forename: Akemi
authors.initials: A
authors.lastname: Osawa
authors.forename: Morton
authors.initials: M
authors.lastname: Scheinberg
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D061067:Antibodies, Monoclonal, Humanized; D005260:Female; D019788:Fluorodeoxyglucose F18 / Q000378:metabolism*; D006801:Humans; D008297:Male; D008875:Middle Aged; D049268:Positron-Emission Tomography / Q000379:methods*; D019275:Radiopharmaceuticals / Q000378:metabolism*; D016706:Still's Disease, Adult-Onset / Q000175:diagnosis*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; C502936:tocilizumab